MTHFR and metabolic syndrome: Additionally, some studies have investigated the effect of the MTHFR C677T polymorphism on MetS in schizophrenia [26,27], type 2 diabetes [28], stroke [29] and colorectal cancer patients [30], however, few studies have examined the risk of MetS in the general population without severe disease.